tiprankstipranks
Trending News
More News >
Leidos Holdings Inc (LDOS)
:LDOS
Advertisement

Leidos Holdings (LDOS) AI Stock Analysis

Compare
1,613 Followers

Top Page

LDOS

Leidos Holdings

(NYSE:LDOS)

Rating:77Outperform
Price Target:
$168.00
▼(-2.86% Downside)
Leidos Holdings demonstrates strong financial performance and strategic growth initiatives, as highlighted in its earnings call. While technical analysis reflects some overbought conditions, the company's valuation appears reasonable. The reaffirmation of guidance and focus on strategic pillars bolster confidence in continued growth.
Positive Factors
Cyber Business
Significant investments in its cyber business position Leidos well to win over $15 billion in pure-cyber opportunities.
Financial Performance
Shares of Leidos are trading up 6% after reporting second-quarter results above consensus and raising the midpoint of its full-year guidance.
Government Contracts
Leidos has aligned with high-priority programs under the new administration, potentially boosting future growth in areas like VA medical exams and FAA modernization.
Negative Factors
Bookings and Backlog
Soft bookings and a sequential 7% decline in backlog present potential challenges for Leidos.
DoD Insourcing Memo
There may be risk from the DoD insourcing memo, which could delay opportunities for Leidos.
Headline Risk
Analyst downgrades Leidos to Neutral due to headline risk across Government Services and a weaker bookings environment.

Leidos Holdings (LDOS) vs. SPDR S&P 500 ETF (SPY)

Leidos Holdings Business Overview & Revenue Model

Company DescriptionLeidos Holdings, Inc. is a leading global science and technology solutions provider that focuses on addressing critical challenges in the defense, aviation, information technology, and biomedical research sectors. The company delivers a broad range of services and solutions in systems integration, data analytics, cybersecurity, and enterprise IT modernization to both government and commercial clients worldwide. Leidos is known for its commitment to innovation, leveraging its expertise to drive advancements in technology and improve operational efficiency for its clients.
How the Company Makes MoneyLeidos makes money primarily through government contracts and commercial services. Its revenue streams are diversified across three main business segments: Defense Solutions, Civil, and Health. The Defense Solutions segment provides a wide array of services including logistics, operational support, and mission systems integration primarily for the U.S. Department of Defense and allied nations. The Civil segment focuses on IT solutions, cybersecurity, and infrastructure modernization for civil agencies, including the FAA and other federal and state government entities. The Health segment offers technology solutions and services for both government and commercial healthcare sectors, including the Department of Veterans Affairs and other public health agencies. Key factors contributing to its earnings include long-term contracts, strategic partnerships, and a focus on high-demand areas such as cybersecurity and digital modernization.

Leidos Holdings Earnings Call Summary

Earnings Call Date:Aug 05, 2025
(Q2-2025)
|
% Change Since: 7.45%|
Next Earnings Date:Nov 04, 2025
Earnings Call Sentiment Positive
The earnings call reflects a positive sentiment overall, with strong financial performance, increased guidance, and strategic initiatives aligning with government funding priorities. While there were some challenges related to procurement delays and DOGE headwinds, the company's proactive measures and robust pipeline indicate confidence in sustained growth.
Q2-2025 Updates
Positive Updates
Record Profitability and Revenue Growth
Leidos reported robust revenue growth of 4.8% year-to-date, with a record EBITDA margin of 15.2% in Q2 and operating cash flow up 28% this quarter.
Full-Year Guidance Raised
Leidos raised its full-year guidance for 2025, with revenue projected between $17 billion and $17.25 billion, an adjusted EBITDA margin in the mid-13% range, and non-GAAP diluted EPS between $11.15 and $11.45.
Strategic Focus on North Star 2030 Strategy
The North Star 2030 strategy, focusing on five growth pillars including space and maritime, digital modernization, and managed health services, is validated by customer engagement and new government funding.
Maritime Growth and Contracts
Leidos is positioned to support the U.S. Navy with autonomous maritime capabilities, securing contracts to convert commercial ships and expand production of unmanned vessels.
Successful AI and Efficiency Initiatives
AI initiatives are on track to save over 0.5 million labor hours, with efficiency gains in finance and software development, contributing to improved profitability.
Strong Q2 Bookings and Pipeline
The company reported a 0.9 book-to-bill ratio in Q2, with a strong pipeline of $70 billion in opportunities over the next 12 months, indicating robust future growth potential.
Negative Updates
Procurement and Award Delays
The procurement process was constrained in the first half of the year, impacting revenue growth due to award delays and ongoing contract reviews.
DOGE Headwinds and Contract Cancellations
The company faced headwinds from Department of Government Efficiency (DOGE) initiatives, including contract cancellations and scope reductions, impacting revenue by approximately 1%.
Company Guidance
During the Leidos Second Quarter 2025 Earnings Conference Call, the company reported several key metrics and provided updated guidance for the year. Leidos achieved a robust revenue growth of 4.8% year-to-date, with a record EBITDA margin of 15.2% in the quarter and a 28% increase in operating cash flow. The company raised its full-year guidance for 2025, anticipating revenues between $17 billion to $17.25 billion, with an adjusted EBITDA margin in the mid-13% range. Non-GAAP diluted EPS is projected between $11.15 and $11.45, and operating cash flow guidance was increased by $200 million to $1.65 billion. The call highlighted Leidos' strategic focus on its North Star 2030 strategy, emphasizing growth pillars such as space and maritime, energy infrastructure, digital modernization, mission software, and managed health services. The company cited significant opportunities from the "One Big Beautiful Bill," which aligns with its core competencies, contributing to a $70 billion pipeline of opportunities, with 75% being new business. Additionally, Leidos reported a strong book-to-bill ratio of 1.3 over the trailing 12 months, supported by recent awards and a robust pipeline, indicating confidence in continued growth despite a dynamic market environment.

Leidos Holdings Financial Statement Overview

Summary
Leidos Holdings exhibits robust financial performance with strong revenue growth, profitability, and cash flow management. The company effectively utilizes its equity to generate returns, but moderate leverage poses a potential risk. Overall, the financial metrics are solid, supporting continued growth.
Income Statement
85
Very Positive
Leidos Holdings has demonstrated strong revenue growth with a consistent upward trend in gross profit and net income, reflecting robust operational efficiency. The TTM gross profit margin stands at 17.23%, with a net profit margin of 7.87%, indicating healthy profitability levels. Additionally, the company shows a positive revenue growth rate of approximately 1.62% from the previous annual report, showcasing its ability to expand its market presence.
Balance Sheet
72
Positive
The balance sheet reflects moderate leverage with a debt-to-equity ratio of 1.35, indicating a balanced approach to using debt for growth. The return on equity (ROE) is solid at 31.3%, demonstrating effective use of equity capital to generate profits. However, the equity ratio of 32.25% suggests a reliance on liabilities, which could pose risks in a downturn.
Cash Flow
78
Positive
Leidos Holdings shows strong cash flow performance with a stable operating cash flow to net income ratio of 1.04, indicating efficient cash generation from operations. The free cash flow has grown by 4.26% year-over-year, underscoring effective capital management. The free cash flow to net income ratio of 0.97 highlights the company's ability to convert earnings into cash.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue17.05B16.66B15.44B14.40B13.74B12.30B
Gross Profit2.99B2.80B2.24B2.08B2.01B1.74B
EBITDA2.25B2.12B931.00M1.41B1.50B1.26B
Net Income1.40B1.25B199.00M685.00M753.00M628.00M
Balance Sheet
Total Assets13.55B13.10B12.70B13.07B13.26B12.51B
Cash, Cash Equivalents and Short-Term Investments930.00M943.00M777.00M516.00M727.00M524.00M
Total Debt598.00M5.41B5.20B5.49B5.67B5.31B
Total Liabilities8.84B8.64B8.44B8.72B8.92B8.64B
Stockholders Equity4.66B4.41B4.20B4.30B4.29B3.86B
Cash Flow
Free Cash Flow1.43B1.24B958.00M857.00M927.00M1.15B
Operating Cash Flow1.50B1.39B1.17B986.00M1.03B1.33B
Investing Cash Flow-445.00M-142.00M-211.00M-313.00M-730.00M-2.81B
Financing Cash Flow-890.00M-1.08B-715.00M-865.00M-113.00M1.45B

Leidos Holdings Technical Analysis

Technical Analysis Sentiment
Positive
Last Price172.94
Price Trends
50DMA
155.68
Positive
100DMA
149.65
Positive
200DMA
151.44
Positive
Market Momentum
MACD
2.02
Negative
RSI
72.72
Negative
STOCH
59.85
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For LDOS, the sentiment is Positive. The current price of 172.94 is above the 20-day moving average (MA) of 162.28, above the 50-day MA of 155.68, and above the 200-day MA of 151.44, indicating a bullish trend. The MACD of 2.02 indicates Negative momentum. The RSI at 72.72 is Negative, neither overbought nor oversold. The STOCH value of 59.85 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for LDOS.

Leidos Holdings Risk Analysis

Leidos Holdings disclosed 2 risk factors in its most recent earnings report. Leidos Holdings reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Leidos Holdings Peers Comparison

Overall Rating
UnderperformOutperform
Sector (57)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
$22.26B16.3530.76%0.99%7.75%325.28%
76
Outperform
$10.37B22.4313.48%14.16%22.25%
74
Outperform
$5.40B16.1321.63%1.28%3.39%-16.78%
71
Outperform
$7.41B14.4222.21%1.52%7.31%-15.86%
68
Neutral
$2.37B6.4512.60%-4.93%497.03%
65
Neutral
$8.46B21.1511.57%4.72%-3.06%
57
Neutral
HK$14.02B9.47-2.83%4.86%9.29%-48.65%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
LDOS
Leidos Holdings
172.94
30.11
21.08%
CACI
Caci International
471.53
10.87
2.36%
EPAM
Epam Systems
149.33
-41.83
-21.88%
G
Genpact
42.37
10.44
32.70%
SAIC
Science Applications
115.18
-4.97
-4.14%
DXC
DXC Technology
13.23
-5.10
-27.82%

Leidos Holdings Corporate Events

Executive/Board ChangesShareholder Meetings
Leidos Holdings Stockholders Approve Key Amendments
Neutral
May 6, 2025

Leidos Holdings, Inc. held its Annual Meeting of Stockholders on May 2, 2025, where stockholders approved amendments to the company’s Certificate of Incorporation. These amendments clarify stockholders’ rights to call special meetings and limit the liability of officers as permitted by law. The meeting also saw the election of board members, approval of executive compensation, and the ratification of Deloitte & Touche LLP as the company’s independent auditor for the fiscal year ending January 2, 2026.

Business Operations and StrategyFinancial Disclosures
Leidos Holdings Reports Strong Q1 2025 Financial Results
Positive
May 6, 2025

Leidos Holdings reported strong financial results for the first quarter of fiscal year 2025, with revenues of $4.2 billion, a 7% increase year-over-year, and net income of $365 million, up 29% from the previous year. The company also announced a change in its backlog policy, which now includes estimated future revenue on task orders expected under sole source IDIQ contracts, resulting in a backlog of $46.3 billion. Leidos secured several significant contracts, including a $205 million task order with the Defense Threat Reduction Agency and a $150 million task order with the Naval Surface Warfare Center Carderock Division, highlighting its strong position in the defense and IT services market.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 05, 2025